Literature DB >> 27613896

Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study.

Maciej L Goniewicz1,2, Michal Gawron2, Danielle M Smith1, Margaret Peng3, Peyton Jacob3, Neal L Benowitz3.   

Abstract

INTRODUCTION: Electronic cigarettes (e-cigarettes) are purported to deliver nicotine aerosol without any toxic combustion products present in tobacco smoke. In this longitudinal within-subjects observational study, we evaluated the effects of e-cigarettes on nicotine delivery and exposure to selected carcinogens and toxicants.
METHODS: We measured seven nicotine metabolites and 17 tobacco smoke exposure biomarkers in the urine samples of 20 smokers collected before and after switching to pen-style M201 e-cigarettes for 2 weeks. Biomarkers were metabolites of 13 major carcinogens and toxicants in cigarette smoke: one tobacco-specific nitrosamine (NNK), eight volatile organic compounds (1,3-butadiene, crotonaldehyde, acrolein, benzene, acrylamide, acrylonitrile, ethylene oxide, and propylene oxide), and four polycyclic aromatic hydrocarbons (naphthalene, fluorene, phenanthrene, and pyrene). Changes in urine biomarkers concentration were tested using repeated measures analysis of variance.
RESULTS: In total, 45% of participants reported complete abstinence from cigarette smoking at 2 weeks, while 55% reported continued smoking. Levels of total nicotine and some polycyclic aromatic hydrocarbon metabolites did not change after switching from tobacco to e-cigarettes. All other biomarkers significantly decreased after 1 week of using e-cigarettes (p < .05). After 1 week, the greatest percentage reductions in biomarkers levels were observed for metabolites of 1,3-butadiene, benzene, and acrylonitrile. Total NNAL, a metabolite of NNK, declined by 57% and 64% after 1 and 2 weeks, respectively, while 3-hydroxyfluorene levels declined by 46% at week 1, and 34% at week 2.
CONCLUSIONS: After switching from tobacco to e-cigarettes, nicotine exposure remains unchanged, while exposure to selected carcinogens and toxicants is substantially reduced. IMPLICATIONS: To our knowledge, this is the first study that demonstrates that substituting tobacco cigarettes with an e-cigarette may reduce user exposure to numerous toxicants and carcinogens otherwise present in tobacco cigarettes. Data on reduced exposure to harmful constituents that are present in tobacco cigarettes and e-cigarettes can aid in evaluating e-cigarettes as a potential harm reduction device.
© The Author 2016. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27613896      PMCID: PMC5234360          DOI: 10.1093/ntr/ntw160

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  33 in total

1.  Quitting smoking among adults--United States, 2001-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-11-11       Impact factor: 17.586

2.  Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers.

Authors:  Stephen S Hecht; Steven G Carmella; Delshanee Kotandeniya; Makenzie E Pillsbury; Menglan Chen; Benjamin W S Ransom; Rachel Isaksson Vogel; Elizabeth Thompson; Sharon E Murphy; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2014-10-21       Impact factor: 4.244

3.  Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.

Authors:  L M Anderson; S S Hecht; D E Dixon; L F Dove; R M Kovatch; S Amin; D Hoffmann; J M Rice
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

4.  Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration.

Authors:  Thomas Eissenberg
Journal:  Tob Control       Date:  2010-02       Impact factor: 7.552

5.  Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors:  Maciej L Goniewicz; Christopher M Havel; Margaret Wilson Peng; Peyton Jacob; Delia Dempsey; Lisa Yu; Wioleta Zielinska-Danch; Bartosz Koszowski; Jan Czogala; Andrzej Sobczak; Neal L Benowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

6.  Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry.

Authors:  Peyton Jacob; Christopher Havel; Do-Hoon Lee; Lisa Yu; Mark D Eisner; Neal L Benowitz
Journal:  Anal Chem       Date:  2008-10-08       Impact factor: 6.986

7.  Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.

Authors:  Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz
Journal:  Tob Control       Date:  2013-03-06       Impact factor: 7.552

8.  Comparison of nicotine and carcinogen exposure with water pipe and cigarette smoking.

Authors:  Peyton Jacob; Ahmad H Abu Raddaha; Delia Dempsey; Christopher Havel; Margaret Peng; Lisa Yu; Neal L Benowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-05       Impact factor: 4.254

9.  Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers).

Authors:  Konstantinos E Farsalinos; Alketa Spyrou; Christos Stefopoulos; Kalliroi Tsimopoulou; Panagiota Kourkoveli; Dimitris Tsiapras; Stamatis Kyrzopoulos; Konstantinos Poulas; Vassilis Voudris
Journal:  Sci Rep       Date:  2015-06-17       Impact factor: 4.379

10.  Effects of Switching to Electronic Cigarettes with and without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and Acrolein.

Authors:  Hayden McRobbie; Anna Phillips; Maciej L Goniewicz; Katie Myers Smith; Oliver Knight-West; Dunja Przulj; Peter Hajek
Journal:  Cancer Prev Res (Phila)       Date:  2015-09
View more
  112 in total

1.  Crotonaldehyde-induced vascular relaxation and toxicity: Role of endothelium and transient receptor potential ankyrin-1 (TRPA1).

Authors:  L Jin; G Jagatheesan; J Lynch; L Guo; D J Conklin
Journal:  Toxicol Appl Pharmacol       Date:  2020-04-19       Impact factor: 4.219

2.  Longitudinal transitions of exclusive and polytobacco electronic nicotine delivery systems (ENDS) use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

Authors:  Cassandra A Stanton; Eva Sharma; Kathryn C Edwards; Michael J Halenar; Kristie A Taylor; Karin A Kasza; Hannah Day; Gabriella Anic; Lisa D Gardner; Hoda T Hammad; Maansi Bansal-Travers; Jean Limpert; Nicolette Borek; Heather L Kimmel; Wilson M Compton; Andrew Hyland
Journal:  Tob Control       Date:  2020-05       Impact factor: 7.552

Review 3.  How close are we to definitively identifying the respiratory health effects of e-cigarettes?

Authors:  Alexsandra Ratajczak; Wojciech Feleszko; Danielle M Smith; Maciej Goniewicz
Journal:  Expert Rev Respir Med       Date:  2018-06-08       Impact factor: 3.772

Review 4.  Electronic nicotine delivery systems and pregnancy: Recent research on perceptions, cessation, and toxicant delivery.

Authors:  Alison Breland; Andrea McCubbin; Kristin Ashford
Journal:  Birth Defects Res       Date:  2019-07-31       Impact factor: 2.344

5.  Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention.

Authors:  Gideon St Helen; Evangelia Liakoni; Natalie Nardone; Newton Addo; Peyton Jacob; Neal L Benowitz
Journal:  Cancer Prev Res (Phila)       Date:  2019-09-25

6.  Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes.

Authors:  Gideon St Helen; Delia A Dempsey; Christopher M Havel; Peyton Jacob; Neal L Benowitz
Journal:  Drug Alcohol Depend       Date:  2017-06-30       Impact factor: 4.492

Review 7.  Biomarkers of exposure to new and emerging tobacco delivery products.

Authors:  Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

8.  Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers.

Authors:  Natalie Voos; Danielle Smith; Lisa Kaiser; Martin C Mahoney; Clara M Bradizza; Lynn T Kozlowski; Neal L Benowitz; Richard J O'Connor; Maciej L Goniewicz
Journal:  Psychopharmacology (Berl)       Date:  2019-11-26       Impact factor: 4.530

9.  Managing nicotine without smoke to save lives now: Evidence for harm minimization.

Authors:  David B Abrams; Allison M Glasser; Andrea C Villanti; Jennifer L Pearson; Shyanika Rose; Raymond S Niaura
Journal:  Prev Med       Date:  2018-06-23       Impact factor: 4.018

10.  Electronic cigarette exposure disrupts blood-brain barrier integrity and promotes neuroinflammation.

Authors:  Nathan A Heldt; Alecia Seliga; Malika Winfield; Sachin Gajghate; Nancy Reichenbach; Xiang Yu; Slava Rom; Amogha Tenneti; Dana May; Brian D Gregory; Yuri Persidsky
Journal:  Brain Behav Immun       Date:  2020-03-31       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.